- Home
- KUKE vs FATE Comparison
KUKE vs FATE Comparison
Compare KUKE & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KUKE
- FATE
- Stock Information
- Founded
- KUKE 2002
- FATE 2007
- Country
- KUKE China
- FATE United States
- Employees
- KUKE N/A
- FATE N/A
- Industry
- KUKE Other Consumer Services
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KUKE Real Estate
- FATE Health Care
- Exchange
- KUKE Nasdaq
- FATE Nasdaq
- Market Cap
- KUKE N/A
- FATE 152.4M
- IPO Year
- KUKE 2021
- FATE 2013
- Fundamental
- Price
- KUKE $4.51
- FATE $1.03
- Analyst Decision
- KUKE
- FATE Hold
- Analyst Count
- KUKE 0
- FATE 8
- Target Price
- KUKE N/A
- FATE $5.43
- AVG Volume (30 Days)
- KUKE 11.7K
- FATE 2.1M
- Earning Date
- KUKE 05-20-2025
- FATE 05-12-2025
- Dividend Yield
- KUKE N/A
- FATE N/A
- EPS Growth
- KUKE N/A
- FATE N/A
- EPS
- KUKE N/A
- FATE N/A
- Revenue
- KUKE $14,784,158.00
- FATE $13,631,000.00
- Revenue This Year
- KUKE N/A
- FATE N/A
- Revenue Next Year
- KUKE N/A
- FATE N/A
- P/E Ratio
- KUKE N/A
- FATE N/A
- Revenue Growth
- KUKE 10.48
- FATE N/A
- 52 Week Low
- KUKE $0.15
- FATE $0.66
- 52 Week High
- KUKE $4.58
- FATE $5.92
- Technical
- Relative Strength Index (RSI)
- KUKE 71.80
- FATE 46.14
- Support Level
- KUKE $4.05
- FATE $0.91
- Resistance Level
- KUKE $4.55
- FATE $1.34
- Average True Range (ATR)
- KUKE 0.29
- FATE 0.15
- MACD
- KUKE -0.06
- FATE -0.03
- Stochastic Oscillator
- KUKE 90.00
- FATE 20.69
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.